Onconetix (ONCO) Stock Statistics & Valuation Metrics

Onconetix has a market cap or net worth of $4.76M. The enterprise value is ―.

Onconetix has 1,555,010 shares outstanding. The number of shares has decreased by -2.65% in one year.

Onconetix’s return on equity (ROE) is -6.11 and return on invested capital (ROIC) is -286.99%.

The current PE Ratio of Onconetix is ―. Onconetix’s PEG ratio is -0.00001.

In the last 12 months, Onconetix had revenue of 2.52M and earned -58.69M in profits. Earnings per share was -1.82K.

In the last 12 months, operating cash flow was -7.51M and capital expenditures -3.87K, giving a free cash flow of -7.51M billion.

Onconetix pays an annual dividend of ―, resulting in a dividend yield of ―

Onconetix upcoming earnings date is ―, ―.

Onconetix as a current ratio of 0.05, with Debt / Equity ratio of 4.93%

In the past 12 months, Onconetix has paid -1.05M in taxes.

Onconetix EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -1.00.

Onconetix has $836.56K in cash and marketable securities with $166.42K in debt, giving a net cash position of $670.13K billion.

Gross margin is 85.41%, with operating margin of -2237.96%, and net profit margin of -2325.21%.

The average price target for Onconetix is ―, which is 11.43% higher than the current price. The consensus rating is ―